Compare
Ascent Industries Co. vs Biolargo, Inc. vs Ecovyst Inc. vs Balchem Corp
| Latest fiscal year | Ascent Industries Co. ACNT | Biolargo, Inc. BLGO | Ecovyst Inc. ECVT | Balchem Corp BCPC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $74.94M | $7.76M | $723.51M | $1.04B |
| Revenue growth (YoY) | -7.2% | -56.3% | +20.9% | +8.8% |
| Gross margin | 23.0% | 43.9% | 21.8% | 35.7% |
| Operating margin | -9.4% | -191.3% | 9.0% | 20.2% |
| Net margin | 1.2% | -195.6% | -9.8% | 14.9% |
| Net income | $867.0K | -$15.19M | -$71.13M | $154.84M |
| EPS (Diluted) | $0.09 | n/a | -$0.61 | $4.75 |
| Operating cash flow | -$519.0K | -$8.30M | $140.31M | $216.56M |
| Free cash flow | -$2.06M | n/a | $69.89M | n/a |
| Cash & equivalents | $57.61M | $3.88M | $197.19M | $74.57M |
| Total assets | $111.94M | $8.31M | $1.26B | $1.69B |
| Total liabilities | $24.95M | $6.79M | $657.54M | $428.84M |
| Shareholders' equity | $86.99M | $4.04M | $603.44M | $1.26B |
| Return on year-end equity | 1.0% | -375.8% | -11.8% | 12.3% |
| Shares outstanding | 9.40M | n/a | 111.81M | 32.06M |
Revenue, most recent five fiscal years
| Fiscal year | Ascent Industries Co. | Biolargo, Inc. | Ecovyst Inc. | Balchem Corp |
|---|---|---|---|---|
| Latest | $74.94M Ended 2025-12-31 | $7.76M Ended 2025-12-31 | $723.51M Ended 2025-12-31 | $1.04B Ended 2025-12-31 |
| 1 year earlier | $80.76M Ended 2024-12-31 | $17.78M Ended 2024-12-31 | $598.29M Ended 2024-12-31 | $953.68M Ended 2024-12-31 |
| 2 years earlier | $193.18M Ended 2023-12-31 | $12.23M Ended 2023-12-31 | $584.85M Ended 2023-12-31 | $922.44M Ended 2023-12-31 |
| 3 years earlier | $261.99M Ended 2022-12-31 | $5.88M Ended 2022-12-31 | $820.16M Ended 2022-12-31 | $942.36M Ended 2022-12-31 |
| 4 years earlier | $334.71M Ended 2021-12-31 | $2.53M Ended 2021-12-31 | $611.20M Ended 2021-12-31 | $799.02M Ended 2021-12-31 |